Review Finds 250 Patients Need Repeat Bone Scans

Why It Matters

Misreported DEXA results can lead to misdiagnosis and inappropriate osteoporosis treatment, affecting patient outcomes and eroding trust in the health system. The recall underscores the need for rigorous quality controls in diagnostic services.

Key Takeaways

• Review covered 1,000+ DEXA scans from 2017‑2022.
• 250 patients flagged for repeat bone density scans.
• 20 cases deemed below expected care standards.
• Issue stemmed from scan reporting, not scan execution.
• Recall program aims completion by May 2026.

Pulse Analysis

Dual‑Energy X‑ray Absorptiometry (DEXA) scans are the clinical gold standard for measuring bone mineral density, guiding osteoporosis diagnosis and fracture‑risk management. Because treatment decisions—such as initiating bisphosphonates or adjusting calcium supplementation—rely directly on the numeric report, any error in interpretation can cascade into inappropriate medication or missed intervention. Health systems therefore embed quality‑control checks around both image acquisition and report generation. When reporting lapses occur, they undermine clinical confidence and may expose patients to unnecessary follow‑up or, conversely, leave genuine bone loss undetected.

The Jersey Health and Care review examined over 1,000 DEXA examinations performed between January 2017 and January 2022 and identified potential reporting concerns. Independent consultants flagged roughly 250 individuals for a repeat scan and classified 20 cases as falling below expected care standards. The authority has launched a recall campaign, promising to complete all re‑scans by the end of May 2026 while urging patients to maintain prescribed osteoporosis medication. Scans conducted after January 2022 were deemed unaffected, and the agency emphasized transparency throughout the outreach.

These events highlight the critical role of independent audits in safeguarding diagnostic integrity, especially in small jurisdictions where specialist resources are limited. Proactive identification of reporting flaws can prevent downstream clinical errors and preserve public trust, a commodity that health ministries cannot afford to lose. Other health systems are likely to review their own DEXA reporting pathways, adopting stricter peer‑review protocols or automated flagging algorithms. For patients, the episode serves as a reminder to stay engaged with follow‑up appointments and to question results that seem inconsistent with their clinical picture.